Cell Isolation Market to Grow with a CAGR of 13.04% through 2028

Rising demand for biopharmaceuticals and increasing government funding for cell-based research is expected to drive the Global Cell Isolation Market growth in the forecast period, 2024-2028.

According to TechSci Research report, “Cell Isolation Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Cell Isolation Market stood at USD 4.03 billion in 2022 and is anticipated to grow with a CAGR of 13.04% in the forecast period, 2024-2028. The global Cell Isolation Market is primarily propelled by initiatives aimed at enhancing research and development by organizations focusing on innovative treatments for incurable diseases such as cancer.

The growth of the market is primarily driven by the increasing number of patients afflicted with cancer and infectious diseases. Furthermore, government funding for cell-based research, emphasis on personalized medicine, and technological advancements are expected to boost market growth. The high growth of the cell isolation market can be attributed to increasing investments in cell biology research and the expanding presence of market players in developing countries. Additionally, the market is anticipated to grow as a result of the rising adoption of advanced equipment and methodologies, driven by increased R&D activities in the pharmaceutical and biotechnology industries.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Cell Isolation Market.”

The surge in demand for biopharmaceuticals, particularly recombinant therapeutic proteins, is anticipated to be a significant catalyst for this expansion. Industry leaders are strategically focused on advancing and commercializing innovative products to meet the requirements of researchers and healthcare professionals, thereby stimulating the demand for cell isolation solutions in the coming years.

Cellular therapies are gaining traction in the treatment of various significant diseases, including neurological disorders like Parkinson's disease and spinal cord injuries, as well as autoimmune conditions such as multiple sclerosis and Crohn's disease. The increase in funding from governmental bodies for cell-based research further underscores its potential in managing chronic ailments like cancer, contributing to the upward trajectory of the global market.

Cancer, the leading cause of death worldwide, accounted for 9.6 million deaths in 2018. According to the report, one in six deaths worldwide is attributable to cancer. Cell therapy holds tremendous promise for treating many other diseases. The rising prevalence of cancer has necessitated in-depth diagnostic and clinical analysis, with human cells playing a crucial role in this research. Furthermore, significant investments by key players in developing cancer treatments using human cells are expected to support the growth of the Cell Isolation/Cell isolation Market.

Moreover, increasing government funding for cell-based research is another factor that has propelled the expansion of the Cell Isolation Market. For instance, in January 2016, the federal government of Canada allocated USD 20 million to the Centre for the Commercialization of Regenerative Medicine. This funding aims to establish a stem-cell therapy development facility in Toronto, Canada. However, ethical concerns and limitations on cell usage for research purposes hinder the market's growth. Nevertheless, the rising investments in cell biology research and the increasing presence of market players in emerging regions are expected to provide lucrative opportunities for the Cell Isolation Market. For example, pharmaceutical companies in India are making substantial investments in R&D to introduce new medications.

Driven by breakthroughs in biotechnology, personalized medicine, and regenerative therapies, cell isolation technologies will play a pivotal role in extracting and purifying specific cell types with unparalleled precision and efficiency. Innovative techniques such as microfluidics, magnetic-activated cell sorting (MACS), and fluorescence-activated cell sorting (FACS) will enable researchers and clinicians to isolate rare cells and exosomes with high sensitivity, allowing for a deeper understanding of diseases and unlocking the potential for targeted therapies. Moreover, the integration of the industry with artificial intelligence and automation will streamline processes, reducing costs and turnaround times, thereby fostering widespread accessibility and adoption of cell-based treatments. Consequently, the cell isolation sector will emerge as a driving force in revolutionizing modern healthcare, leading to groundbreaking advancements and improved patient outcomes.

The Global Cell Isolation Market is segmented into product, cell type, source, technique, application, end user, regional distribution, and company.

Based on cell type, the human cell segment is anticipated to dominate the cell isolation market during the forecast period. This can be attributed to the growing focus on human and cancer research, as well as the diverse applications of isolated human cells in biopharmaceutical development, clinical trials, and research. Additionally, favorable reimbursement policies for personalized medicine in developed countries further drive the demand for human cell isolation. According to the Cancer Facts and Figures 2022 report published by the American Cancer Society, it is projected that there were 1.9 million new cancer cases in the United States in 2022. Consequently, the rising number of cancer cases is expected to stimulate initiatives by market players, thereby augmenting the segment's growth throughout the forecast period.

During the forecast period, various initiatives by key market players are expected to propel the market's growth. For example, in May 2022, Akadeum Life Sciences Inc. announced the expansion of its cell isolation product portfolio by introducing a new human B cell isolation product and updating the protocol for its existing human isolation kits. Similarly, in April 2022, Applied Cells Inc. and STEMCELL Technologies collaborated to deliver a new high-performance cell separation solution, combining Applied Cells' MARS platform with STEMCELL's EasySep immunomagnetic cell separation kits. This partnership aims to automate and enhance the efficiency of isolating high-quality cells from various sample types, including whole blood, bone marrow, apheresis products, and dissociated tissue, benefiting researchers worldwide. Additionally, STEMCELL's cell isolation reagents will expand the applications of the MARS platform and support the specialized requirements of researchers who need to isolate extremely low-frequency cancer cells from human samples. Hence, initiatives undertaken by key market players are expected to significantly contribute to the growth of this segment.

Based on region, North America segment is expected to grow during the forecast period. North America is projected to hold a significant market share in the cell isolation market during the forecast period. This can be attributed to the well-established pharmaceutical and biotech industries in the region, along with the high adoption of technologically advanced solutions, particularly in the United States. The presence of research universities conducting extensive studies on cell therapies has also resulted in a substantial demand for cell separation solutions.

The prevalence of chronic and infectious diseases, including the ongoing COVID-19 pandemic, has further driven the need for cell isolation solutions in both research and clinical applications. For instance, according to the 2021 report by the International Diabetes Federation, the number of people with diabetes in North America and the Caribbean region is expected to rise from 50.5 million in 2021 to 63 million by 2045. Moreover, a report published by the Canadian Cancer Society in May 2022 estimated that 3,200 Canadians were diagnosed with brain and spinal cord cancer in 2022, with 1,850 men and 1,350 women affected. Consequently, the demand for cell isolation products is poised to grow in North America, driven by therapeutic and research requirements, thereby fostering market expansion. 

Major companies operating in Global Cell Isolation Market are:

• Becton, Dickinson & Company
• Merck KGaA (Millipore Sigma)
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• Terumo Corporation
• PluriSelect Life Science UG & Co. KG
• Danaher Corporation (Cytiva)
• STEMCELL Technologies Inc.
• Corning Inc.
• Akadeum Life Sciences Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“Significant growth in the medical and pharmaceutical industries is a key factor contributing to a positive market outlook. Moreover, there is an increasing emphasis on cell-based research, which is driving market growth. Researchers actively utilize isolated cells to develop innovative cell therapies and treatments for chronic medical conditions. Cell isolation technologies are widely employed by pharmaceutical manufacturers to enhance drug discovery and develop more effective drugs. The growing demand for personalized medicines is also fueling market growth. Additionally, the development of advanced separation tools for proteins, nucleic acids, chromatin, and other complex cells is playing a pivotal role in market expansion. Furthermore, extensive research and development (R&D) activities in the field of biotechnology, coupled with favorable government policies, are expected to drive market growth.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Cell Isolation Market Segmented By Product (Consumables and Instruments), By Cell Type (Human Cells and Animal Cells), By Source (Bone Marrow, Cord Blood/Embryonic Stem Cells, Adipose Tissue), By Technique (Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, Filtration-Based Cell Isolation), By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In Vitro Diagnostics, Others), By End User (Biotechnology and Biopharmaceutical Companies, Research Laboratories and Institutes, Hospitals and Diagnostic Laboratories, Cell Banks), By Region and Competition, Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Cell Isolation Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Cell Isolation Market.